Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain Injury
NCT ID: NCT06958406
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2025-05-06
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, magnetic resonance imaging (MRI) or functional MRI (fMRI) examinations were performed in patients with mild or moderate TBI with aim to explore the association between structural and functional disconnection caused by cerebral contusion and TBI-induced CCS, and to screen out the neural anatomical structures to predict CCS following TBI, providing therapy targets for prevention and treatment of CCS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Combined Detection of Different Blood Biomarkers in the Diagnosis and Treatments of Traumatic Brain Injury
NCT06854835
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
NCT02868684
Brain Volume and Cardiac Function in Heart Failure
NCT06623344
Functional MRI to Assess Brain Damage in Cardiac Arrest Patients
NCT05966389
The Research for New Clinical Diagnostic Strategy of Specific Biomarkers for Traumatic Brain Injury
NCT03976492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TBI-CCS
Patients with TBI-induced CCS, including myocardial injury, arrhythmia or heart failure.
No interventions assigned to this group
Non TBI-CCS
Patients with non TBI-induced CCS.
No interventions assigned to this group
Normal control
Normal healthy people.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-80 years old
* Admitted to hospital within 24 hours of injury
* Mild or moderate TBI (Glasgow Coma Scale score of 9-15)
* Signed consent form
Exclusion Criteria
* A history of stroke, TBI, intracranial tumor or surgery in the past 1 year
* A history of coronary heart disease, structural heart disease and other primary heart diseases or suspected cardiac symptoms prior to injury
* Causes of abnormal cardiac biomarkers such as renal insufficiency, severe anemia, sepsis, cardiotoxic drugs and so on
* Not suitable for MRI examinations, such as pregnant women and those with metal implants in the body
* Undergo surgery prior to MRI examinations or cardiac testing
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 6th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hao Chen, MD, PhD
Associate Professor, Chief Physician, Graduate Supervisor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hao Chen, M.D., Ph.D.
Role: STUDY_DIRECTOR
Shanghai 6th Peoples' Hospital
Lai Wei, M.D.
Role: PRINCIPAL_INVESTIGATOR
Shanghai 6th Peoples' Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai 6th People's Hospital
Shanghai, , China
Shanghai Sixth People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-KY-136(K)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.